local
Hay desesperación en el mundo por los medicamentos para perder peso. Pero las grandes farmacéuticas no pueden promocionarlos
Summary by The El Paso Editorial Desk · Based on reporting by CNN Newsource , KVIA ABC-7
· July 21, 2026
· 9 min read
Por Anna Cooban, CNN La temperatura alcanzaba los 33 grados centígrados. El sudor era abundante. Y yo caminaba hacia una exposición sobre la “experiencia de la obesidad” en la concurrida ribera del río en Londres, financiada por una empresa farmacéutica valorada en US$ 220.000 millones. Era el se...
Story provenance No corrections
Summary created by The El Paso Editorial Desk — automated, rule-governed Original reporting CNN Newsource, KVIA ABC-7 Original story Read at the source Source published Jul 21, 2026 Indexed here Jul 21, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway Y yo caminaba hacia una exposición sobre la “experiencia de la obesidad” en la concurrida ribera del río en Londres, financiada por una empresa farmacéutica valorada en US$ 220.
Why this matters in The El Paso
El Paso residents may be surprised to learn that the aggressive marketing of weight loss medications seen on US television and online is not the norm in most countries. In fact, the majority of the world prohibits direct-to-consumer advertising of prescription medications, with the US and New Zealand being the only exceptions. This means that pharmaceutical companies like Novo Nordisk, which manufactures popular weight loss medications Ozempic and Wegovy, must resort to creative strategies to reach potential customers in other countries. As El Pasoans navigate the complex and often competitive market for weight loss solutions, it's worth considering the role of marketing and advertising in shaping our perceptions of these products. With the city's high rates of obesity and related health issues, it's crucial to separate hype from credible information and consult with healthcare professionals before making decisions about weight loss medications.
About this story
Original reporting by KVIA ABC-7 . The El Paso surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KVIA ABC-7 . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 21, 2026 ·
Source: KVIA ABC-7 ·
Reading time: 9 min
Frequently asked about this story
What is this story about? Por Anna Cooban, CNN La temperatura alcanzaba los 33 grados centígrados. El sudor era abundante. Y yo caminaba hacia una exposición sobre la “experiencia de la obesidad” en la concurrida ribera del río en Londres, financiada por una empresa farmacéutica valorada en US$ 220.000 millones. Era el se...
When was this published? This article was first published on July 21, 2026 by KVIA ABC-7 and curated for The El Paso readers.
Who reported this story? This story was reported by CNN Newsource at KVIA ABC-7. To learn more about how The El Paso selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The El Paso, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter